Search research articles
Contact Us
Filters
Showing results (321-330 of 346) with videos related to
Page
of 35
Sort By:
Molecular Pharmaceutics
|
September 29, 2022
High-Contrast Detection of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery
Servando Hernandez Vargas, Solmaz AghaAmiri, Sukhen C Ghosh, et al.
Pancreas
|
September 14, 2017
Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy
Reza Nejati, Jennifer B Goldstein, Daniel M Halperin, et al.
Pancreas
|
September 29, 2020
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors
Jennifer R Eads, Diane Reidy-Lagunes, Heloisa P Soares, et al.
Human Vaccines & Immunotherapeutics
|
January 8, 2025
Considering the impact of vaccine communication in the COVID-19 pandemic among adults in Canada: A qualitative study of lessons learned for future vaccine campaigns
Jeanna Parsons Leigh, Stephana Julia Moss, Jade MacDonald, et al.
Nature Medicine
|
October 8, 2021
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
V Ratziu, L de Guevara, R Safadi, et al.
British Journal of Cancer
|
March 11, 2020
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials
Namrata Vijayvergia, Arvind Dasari, Mengying Deng, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine Tumor
Jin Guo, Kever A Lewis, Laura Prakash, et al.
Endocrine-Related Cancer
|
February 19, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directives
C R C Pieterman, S M Sadowski, J E Maxwell, et al.
Endocrine-Related Cancer
|
January 22, 2021
Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms
James C Yao, Jonathan Strosberg, Nicola Fazio, et al.
Oral Oncology
|
March 9, 2024
Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study
L Guimaraes de Sousa, S Liu, P Bhosale, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 346) with videos related to
Sort By:
Page
of 35
Molecular Pharmaceutics
|
September 29, 2022
High-Contrast Detection of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery
Servando Hernandez Vargas, Solmaz AghaAmiri, Sukhen C Ghosh, et al.
Pancreas
|
September 14, 2017
Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy
Reza Nejati, Jennifer B Goldstein, Daniel M Halperin, et al.
Pancreas
|
September 29, 2020
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors
Jennifer R Eads, Diane Reidy-Lagunes, Heloisa P Soares, et al.
Human Vaccines & Immunotherapeutics
|
January 8, 2025
Considering the impact of vaccine communication in the COVID-19 pandemic among adults in Canada: A qualitative study of lessons learned for future vaccine campaigns
Jeanna Parsons Leigh, Stephana Julia Moss, Jade MacDonald, et al.
Nature Medicine
|
October 8, 2021
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
V Ratziu, L de Guevara, R Safadi, et al.
British Journal of Cancer
|
March 11, 2020
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials
Namrata Vijayvergia, Arvind Dasari, Mengying Deng, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine Tumor
Jin Guo, Kever A Lewis, Laura Prakash, et al.
Endocrine-Related Cancer
|
February 19, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directives
C R C Pieterman, S M Sadowski, J E Maxwell, et al.
Endocrine-Related Cancer
|
January 22, 2021
Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms
James C Yao, Jonathan Strosberg, Nicola Fazio, et al.
Oral Oncology
|
March 9, 2024
Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study
L Guimaraes de Sousa, S Liu, P Bhosale, et al.
Page
of 35